Sort
48,018 grants matching “immunotherapy”
Cancer Center Support (Core) Grant
$3,572,644Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2016 · CA
Cancer Center Support (Core) Grant
$3,572,644Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2018 · CA
Cancer Center Support (Core) Grant
$3,572,644Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2015 · CA
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,571,550Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Tissue and organ specific human B cell immunity
$3,563,564Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2019 · AI
CANCER CENTER SUPPORT GRANT
$3,562,737University Of Colorado Denver · P30 · FY2005 · CA
CANCER CENTER SUPPORT GRANT
$3,562,736University Of Colorado Denver · P30 · FY2004 · CA
Tissue and organ specific human B cell immunity
$3,562,534Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2020 · AI
Tissue and organ specific human B cell immunity
$3,558,962Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2021 · AI
Tissue and organ specific human B cell immunity
$3,556,205Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2022 · AI
THERAPY OF CML
$3,556,156Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2006 · CA
Assessing the effects of oral pre-exposure prophylaxis on pharmacokinetics of monoclonal and vaccine-induced antibodies among women vulnerable to HIV-1
$3,554,273Yunda Huang · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Tissue and organ specific human B cell immunity
$3,552,993Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2023 · AI
THERAPY OF CML
$3,552,240Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
A NEW PARADIGM FOR THE TREATMENT OF OVARIAN CANCER: THE USE OF EPIGENETIC THERAPY TO SENSITIZE PATIENTS TO IMMUNOTHERAPY AND CHEMOTHERAPY
$3,548,150The Johns Hopkins University · · FY2014 · Department of the Army
Sirtuins and nuclear receptors in aging and age-associated diseases
$3,547,152Xiaoling Li · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
COG NCTN Network Group Operations Center - Year 10 Administrative Supplements
$3,541,929Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA
THERAPY OF CML
$3,538,057University Of Texas Md Anderson Can Ctr · P01 · FY2005 · CA
The Therapy of CML
$3,537,028Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Calcineurin Mediates the Synergistic Toxicity of Tau and Aβ Oligomers
$3,532,750Giulio Taglialatela · University Of Texas Med Br Galveston · RF1 · FY2019 · AG
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$3,531,526Martin Cheever · Fred Hutchinson Cancer Research Center · UM1 · FY2019 · CA
CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH CONSORTIUM
$3,529,959University Of California San Diego · P01 · FY2002 · CA
Novel hematopoietic stem cell engineering and transplantation approaches for HIV cure
$3,528,529Paula M Cannon · University Of Southern California · U19 · FY2023 · HL
COG NCTN Year 11 BIQSFP Progress Report
$3,527,865Douglas S. Hawkins · Public Health Institute · U10 · FY2024 · CA
AMERICAN COLLEGE OF SURGEONS ONCOLOGY GROUP
$3,522,577Duke University · U10 · FY2004 · CA